Ablynx is Biotechnology in Belgium that focus on biopharmaceutical products business. Founded in 2001. They cover business area such as manufacturer, biopharmaceutical product, protein base therapeutic, treatment, inflammation, hematology, immuno-oncology, disease, their patented product, nanobodie, single-chain antibody fragment, drug, conventional antibody, small chemical molecule, enable patient, society.
2001
( 23 years old in 2024 )
Biopharmaceutical Products
-
Technologiepark 21
9052 Ghent
Belgium
Private
manufacturerbiopharmaceutical productprotein base therapeutictreatmentinflammationhematologyimmuno-oncologydiseasetheir patented productnanobodiesingle-chain antibody fragmentdrugconventional antibodysmall chemical moleculeenable patientsociety
* We use standard office opening hours in near Ablynx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ablynx is Biotechnology business from Belgium that founded in 2001 (23 years old in 2024), Ablynx business is focusing on Biopharmaceutical Products.
Ablynx headquarter office and corporate office address is located in Technologiepark 21 9052 Ghent Belgium.
Ablynx was founded in Belgium.
In 2024, Ablynx is currently focus on biopharmaceutical products sector.
Above is snippet of Google Trends for "biopharmaceutical products" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ablynx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
